3.23.1 html 55 136 1 false 16 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://lsmg/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - BALANCE SHEETS Sheet http://lsmg/role/BalanceSheets BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://lsmg/role/BalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - STATEMENTS OF OPERATIONS Sheet http://lsmg/role/StatementsOfOperations STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - STATEMENTS OF CASH FLOWS Sheet http://lsmg/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 00000006 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY (EQUITY) Sheet http://lsmg/role/StatementsOfChangesInStockholdersDeficiencyEquity STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY (EQUITY) Statements 6 false false R7.htm 00000007 - Disclosure - BASIS OF PRESENTATION AND NATURE OF OPERATIONS Sheet http://lsmg/role/BasisOfPresentationAndNatureOfOperations BASIS OF PRESENTATION AND NATURE OF OPERATIONS Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://lsmg/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - TRANSACTIONS WITH LODE-STAR GOLD INC. Sheet http://lsmg/role/TransactionsWithLode-starGoldInc. TRANSACTIONS WITH LODE-STAR GOLD INC. Notes 9 false false R10.htm 00000010 - Disclosure - PHARMACEUTICAL DEVELOPMENT PROJECT Sheet http://lsmg/role/PharmaceuticalDevelopmentProject PHARMACEUTICAL DEVELOPMENT PROJECT Notes 10 false false R11.htm 00000011 - Disclosure - CAPITAL STOCK Sheet http://lsmg/role/CapitalStock CAPITAL STOCK Notes 11 false false R12.htm 00000012 - Disclosure - RELATED PARTY TRANSACTIONS AND AMOUNTS DUE Sheet http://lsmg/role/RelatedPartyTransactionsAndAmountsDue RELATED PARTY TRANSACTIONS AND AMOUNTS DUE Notes 12 false false R13.htm 00000013 - Disclosure - INCOME TAXES Sheet http://lsmg/role/IncomeTaxes INCOME TAXES Notes 13 false false R14.htm 00000014 - Disclosure - BASIS OF PRESENTATION AND NATURE OF OPERATIONS (Policies) Sheet http://lsmg/role/BasisOfPresentationAndNatureOfOperationsPolicies BASIS OF PRESENTATION AND NATURE OF OPERATIONS (Policies) Policies 14 false false R15.htm 00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://lsmg/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 15 false false R16.htm 00000016 - Disclosure - CAPITAL STOCK (Tables) Sheet http://lsmg/role/CapitalStockTables CAPITAL STOCK (Tables) Tables http://lsmg/role/CapitalStock 16 false false R17.htm 00000017 - Disclosure - INCOME TAXES (Tables) Sheet http://lsmg/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://lsmg/role/IncomeTaxes 17 false false R18.htm 00000018 - Disclosure - BASIS OF PRESENTATION AND NATURE OF OPERATIONS (Details Narrative) Sheet http://lsmg/role/BasisOfPresentationAndNatureOfOperationsDetailsNarrative BASIS OF PRESENTATION AND NATURE OF OPERATIONS (Details Narrative) Details http://lsmg/role/BasisOfPresentationAndNatureOfOperationsPolicies 18 false false R19.htm 00000019 - Disclosure - TRANSACTIONS WITH LODE-STAR GOLD INC. (Details Narrative) Sheet http://lsmg/role/TransactionsWithLode-starGoldInc.DetailsNarrative TRANSACTIONS WITH LODE-STAR GOLD INC. (Details Narrative) Details http://lsmg/role/TransactionsWithLode-starGoldInc. 19 false false R20.htm 00000020 - Disclosure - PHARMACEUTICAL DEVELOPMENT PROJECT (Details Narrative) Sheet http://lsmg/role/PharmaceuticalDevelopmentProjectDetailsNarrative PHARMACEUTICAL DEVELOPMENT PROJECT (Details Narrative) Details http://lsmg/role/PharmaceuticalDevelopmentProject 20 false false R21.htm 00000021 - Disclosure - CAPITAL STOCK (Details) Sheet http://lsmg/role/CapitalStockDetails CAPITAL STOCK (Details) Details http://lsmg/role/CapitalStockTables 21 false false R22.htm 00000022 - Disclosure - CAPITAL STOCK (Details Narrative) Sheet http://lsmg/role/CapitalStockDetailsNarrative CAPITAL STOCK (Details Narrative) Details http://lsmg/role/CapitalStockTables 22 false false R23.htm 00000023 - Disclosure - RELATED PARTY TRANSACTIONS AND AMOUNTS DUE (Details Narrative) Sheet http://lsmg/role/RelatedPartyTransactionsAndAmountsDueDetailsNarrative RELATED PARTY TRANSACTIONS AND AMOUNTS DUE (Details Narrative) Details http://lsmg/role/RelatedPartyTransactionsAndAmountsDue 23 false false R24.htm 00000024 - Disclosure - INCOME TAXES (Details) Sheet http://lsmg/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://lsmg/role/IncomeTaxesTables 24 false false R25.htm 00000025 - Disclosure - INCOME TAXES (Details 2) Sheet http://lsmg/role/IncomeTaxesDetails2 INCOME TAXES (Details 2) Details http://lsmg/role/IncomeTaxesTables 25 false false R26.htm 00000026 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://lsmg/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://lsmg/role/IncomeTaxesTables 26 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept ResearchAndDevelopmentInProcess in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. lsmg-10k.htm 36, 38, 2637, 2732 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 6 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. lsmg-10k.htm 3934, 3945, 3946, 3952, 3953 [dq-0521-EntityPublicFloat-Missing] Submission type 10-K should have a non-empty value for EntityPublicFloat in the Required Context. lsmg-10k.htm [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:DocumentAnnualReport, dei:DocumentTransitionReport, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 - lsmg-10k.htm 28, 30, 31, 75 [DQC.US.0057.9728] One of the following elements CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents, CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations should appear as the opening and closing balance in the cash flow statement using the group http://lsmg/role/StatementsOfCashFlows. Instead the following balance items have been used in this statement CashAndCashEquivalentsAtCarryingValue. Due to the implementaion of ASU-2016-18 at least one of the opening and closing balance items listed must be used in the cash flow statement. - https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd 2790 - https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd 2790 lsmg-10k.htm lsmg-20221231.xsd lsmg-20221231_cal.xml lsmg-20221231_def.xml lsmg-20221231_lab.xml lsmg-20221231_pre.xml lsmg-ex31_1.htm lsmg-ex32_1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true